InterCure Ltd (INCR) – StreetInsider.com Reports
-
InterCure Ltd (INCR) Reports Prelim FY23 Figures
-
InterCure Ltd (INCR) Issues Update Regarding Nir Oz Facility
-
InterCure Ltd (INCR) to Acquire Leon Cannabis Pharmacy Chain
-
InterCure (INCR) Wins Cannolam Arbitration Proceeding
-
InterCure Ltd (INCR) Issues Update Regarding the Security Situation in Israel
-
InterCure Ltd (INCR) Announces Proposed Voluntary Delisting from the Toronto Stock Exchange
-
InterCure Ltd. (INCR) PT Lowered to $5 at TD Cowen
-
InterCure Ltd (INCR) and Intercure (INCR) Enter International Strategic Agreement
-
INC Research Holdings (INCR) reports Q3 results
-
Canaccord Genuity Upgrades InterCure Ltd. (INCR) to Spec. Buy
-
InterCure Ltd. (INCR) PT Lowered to $7 at Cowen
-
InterCure Ltd (INCR) Reports Q4 Revenue of $33M, Net Loss of $1M
-
InterCure Ltd (INCR) Guides Record Q4 Revenue of $33M, FY Net Income of $1M
-
InterCure Ltd (INCR) Enters Partnership with Clever Leaves (CLVR)
-
InterCure Ltd (INCR) Enters Partnership with Altman Health
-
InterCure Ltd (INCR) Acquires Medical Cannabis Producer “Better” for $35M in Stock
-
InterCure Ltd (INCR) CEO Purchases Over 420,000 Company's Shares in the Open Market
-
Aphria (APHA) Announces Strategic Supply Agreement With Canndoc
-
Viking Global's 13F Shows New Stakes in Alibaba (BABA), BioMarin (BMRN) and Western Digital (WDC), Increase in Microsoft (MSFT), Wells Fargo (WFC) (More...)
-
JANA Shows New Stakes in Apple (AAPL), Boston Scientific (BSX), Dropbox (DBX), iQIYI (IQ) (more..) -13F
-
JANA Partners Enters Facebook (FB), Comcast (CMCSA) , Teva (TEVA) (more...) - 13F
-
Viking Global's 13F Shows New Stake in Time Warner (TWX), Netease (NTES), PACCAR (PCAR), Exits Deere (DE) (more...)
-
INC Research Holdings (INCR) PT Raised to $50 at Baird, 'We Think Recovery Trade Has Legs'
-
Barclays Starts INC Research Holdings (INCR) at Equalweight, 'Too Early to Call a Comeback'
-
INC Research Holdings (INCR) PT Lowered to $46 at Baird Following 3Q Miss
-
INC Research Holdings (INCR) PT Lowered to $45 at Wells Fargo on Q3 Report; 'Not Buying this Dip'
-
INC Research Holdings (INCR) Misses Q3 EPS by 8c, Miss on Revenues; Q4 EPS/Revenue Outlook Below Consensus Projections
-
Jefferies Upgrades INC Research Holdings (INCR) to Buy
-
Mizuho Securities Starts INC Research Holdings (INCR) at Neutral
-
UPDATE: Goldman Sachs Reinstates INC Research Holdings (INCR) at Buy
-
INC Research Holdings (INCR) Reports In-Line Q2 EPS, Beats on Revenues
-
Jefferies Downgrades INC Research Holdings (INCR) to Hold
-
UPDATE: William Blair Downgrades INC Research Holdings (INCR) to Market Perform Ahead Of Merger Agreement
-
KeyBanc Upgrades INC Research Holdings (INCR) to Overweight
-
SunTrust Robinson Humphrey Upgrades INC Research Holdings (INCR) to Buy
-
Baird Upgrades INC Research Holdings (INCR) to Outperform
-
Pre-Open Stock Movers 05/10: (PRTO) (NVDA) (INCR) Higher; (YELP) (VSI) (FOSL) Lower (more...)
-
INC Research Holdings (INCR) Tops Q1 EPS by 1c
-
INC Research (INCR) to Merge with inVentiv Health
-
Wells Fargo Downgrades 7 Names Overnight
-
Pre-Open Stock Movers 03/30: (EXTR) (NQ) (COP) Higher; (LULU) (TNXP) (CVE) Lower (more...)
-
After-Hours Stock Movers 03/29: (EXTR) (PRGS) (COP) Higher; (LULU) (TNXP) (CVE) Lower (more...)
-
Gartner (IT) Set to Join S&P 500; Dun & Bradstreet (DNB), Wintrust Financial (WTFC) and INC Research (INCR) to Join S&P MidCap 400; Heska (HSKA) to Join S&P SmallCap 600
-
SunTrust Robinson Humphrey Downgrades INC Research Holdings (INCR) to Hold
-
INC Research Holdings (INCR): Buy On Weakness - Jefferies
-
Goldman Sachs Downgrades INC Research Holdings (INCR) to Buy
-
INC Research Holdings (INCR) Reports In-Line Q4 EPS
-
INC Research Holdings (INCR) PT Raised to $59 at Jefferies
-
First Analysis Starts INC Research Holdings (INCR) at Equal Weight
-
Cellectar Biosciences (CLRB) Taps INC Research (INCR) to Oversee CLR Phase 2 in Multiple Myeloma, Select Hematologic Malignancies
Back to INCR Stock Lookup